SFTPA2 and asthma: Our group showed that SP-A extracted from bronchoalveolar lavage (BAL) from participants with asthma ineffectively reduced inflammation due to M. pneumoniae infection of airway epithelial cells compared to SP-A extracted from participants without asthma (2).